NephroPlus Share Price in Focus; Philippines Subsidiary Acquires Dialysis Centre Assets

NephroPlus (Nephrocare Health Services Limited) has announced that its overseas step-down wholly owned subsidiary, Nephrocare Health Care Services Philippines Inc., has entered into an Asset Transfer Agreement for the acquisition of dialysis centre assets in the Philippines. 

The transaction is aimed at expanding the company's dialysis care network in the international market.  

Subsidiary Signs Asset Transfer Agreement 

The agreement has been signed with Pag-Asa Dialysis and Diagnostic Centre for the acquisition of identified assets related to a dialysis centre located in Ipil, Zamboanga Sibugay, Philippines. 

The transaction was executed on June 22, 2026.  

Deal Value Stands at Php 80.64 million 

According to the company's disclosure, the acquisition will be completed for a total consideration of Php 80.64 million. 

The purchase is subject to the terms and conditions specified in the Asset Transfer Agreement.  

Expansion of International Dialysis Network 

The acquired assets relate to an operational dialysis centre in the Philippines. 

The transaction is expected to strengthen NephroPlus' presence in Southeast Asia and support the expansion of its international dialysis services network.  

Read More: Maharashtra Smart Meter Installations Cross 1.5 Crore Mark! 

NephroPlus Health Services Share Price Performance 

As of 23 June 2026, NephroPlus Health Services share price was closed at ₹695.00 per share, reflecting a decline of 4.07% from the previous trading session. 

Conclusion 

NephroPlus' Philippines-based step-down subsidiary has signed an agreement to acquire dialysis centre assets for Php 80.64 million. The transaction strengthens the company's presence in the Philippines and supports its strategy of expanding healthcare services across international markets. 

Want to read stock market updates in Hindi? Angel One News gives comprehensive share market news in Hindi. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.